Vir Biotechnology Inc (NASDAQ: VIR) open the trading on Thursday, with a bit cautious approach as it glided -4.29% to $10.05, before settling in for the price of $10.50 at the close. Taking a more long-term approach, VIR posted a 52-week range of $6.56-$14.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 532.77% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -34.12%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 15.42%. This publicly-traded company’s shares outstanding now amounts to $136.71 million, simultaneously with a float of $87.71 million. The organization now has a market capitalization sitting at $1.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $8.36, while the 200-day Moving Average is $8.76.
Vir Biotechnology Inc (VIR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vir Biotechnology Inc’s current insider ownership accounts for 36.31%, in contrast to 49.09% institutional ownership. According to the most recent insider trade that took place on Jan 08 ’25, this organization’s Director sold 10,960 shares at the rate of 12.52, making the entire transaction reach 137,219 in total value, affecting insider ownership by 1,312,391.
Vir Biotechnology Inc (VIR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
Vir Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 15.42% and is forecasted to reach -3.54 in the upcoming year.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Let’s observe the current performance indicators for Vir Biotechnology Inc (VIR). It’s Quick Ratio in the last reported quarter now stands at 8.94. The Stock has managed to achieve an average true range (ATR) of 0.99. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 17.60.
In the same vein, VIR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.92, a figure that is expected to reach -0.87 in the next quarter, and analysts are predicting that it will be -3.54 at the market close of one year from today.
Technical Analysis of Vir Biotechnology Inc (VIR)
[Vir Biotechnology Inc, VIR] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 41.97% While, its Average True Range was 1.15.
Raw Stochastic average of Vir Biotechnology Inc (VIR) in the period of the previous 100 days is set at 44.23%, which indicates a major rise in contrast to 39.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 204.02% that was higher than 99.93% volatility it exhibited in the past 100-days period.
